Search

Showing "11154" results for ""

Age-dependent immune recovery in treatment-naïve children not affected by pre-HAART viral load

South Africa slow to meet ARV targets, says new treatment watchdog

Initial NNRTI-based HAART regimens are sustained longer than PI-based HAART, Canadian study shows

HIV treatment proving effective for children in Côte d'Ivoire

Higher immune system activation prior to seroconversion leads to faster CD4 T-cell loss

Abacavir/3TC once daily pill gets scientific approval as Kivexa in Europe

Microbicide Development Programme drops Emmelle for PRO 2000

Rare sexually transmitted infection seen in a cluster of HIV-positive men

Spontaneous hepatitis C virus clearance occurs in up to 42% recently infected, HIV-negative IDUs

Does long-term HAART lead to a resurgence in immune activation and fall in CD4 count?

India: Global Fund boss optimistic on HIV progress; controversy continues on size of epidemic

Ukraine strikes deal with Clinton Foundation for cheaper HIV drugs

UK gives $5.3 million to Global Fund in bid to trigger US cash release by month's close

Rare case of lopinavir resistance in first line treatment reported

Electronic learning tools and distance boost delivery of HIV prevention by NGOs

BMI valuable tool for assessing when to start ARVs in resource limited settings

Immune reconstitution inflammatory syndrome (IRIS) in the developing world

Short course AZT for breast-feeding mothers: warning of viral rebound when AZT stopped

Receive the latest HIV research and conference news

Showing "11154" results for ""

Age-dependent immune recovery in treatment-naïve children not affected by pre-HAART viral load

South Africa slow to meet ARV targets, says new treatment watchdog

Initial NNRTI-based HAART regimens are sustained longer than PI-based HAART, Canadian study shows

HIV treatment proving effective for children in Côte d'Ivoire

Higher immune system activation prior to seroconversion leads to faster CD4 T-cell loss

Abacavir/3TC once daily pill gets scientific approval as Kivexa in Europe

Microbicide Development Programme drops Emmelle for PRO 2000

Rare sexually transmitted infection seen in a cluster of HIV-positive men

Spontaneous hepatitis C virus clearance occurs in up to 42% recently infected, HIV-negative IDUs

Does long-term HAART lead to a resurgence in immune activation and fall in CD4 count?

India: Global Fund boss optimistic on HIV progress; controversy continues on size of epidemic

Ukraine strikes deal with Clinton Foundation for cheaper HIV drugs

UK gives $5.3 million to Global Fund in bid to trigger US cash release by month's close

Rare case of lopinavir resistance in first line treatment reported

Electronic learning tools and distance boost delivery of HIV prevention by NGOs

BMI valuable tool for assessing when to start ARVs in resource limited settings

Immune reconstitution inflammatory syndrome (IRIS) in the developing world

Short course AZT for breast-feeding mothers: warning of viral rebound when AZT stopped

Receive the latest HIV research and conference news